FAT1 and cholangiocarcinoma: Other studies, however, pointed to a potential tumor suppressor role, as loss of heterozygosity and homozygous deletions were detected in astrocytic cancers and in oral tumors [41], [42], whereas loss of membraneous Fat1 was reported to correlate with more aggressive intrahepatic cholangiocarcinomas [43].